Telecom Plus PLC (the "Company")
Notification and public disclosure by directors/persons discharging managerial responsibilities and persons closely associated with them
Telecom Plus PLC received notification today that Melvin Lawson, Non-Executive Director, disposed of 700,000 ordinary shares in the Company of 5p each ("Ordinary Shares") on 26 June 2020 ("the Disposal"). The Disposal was conducted through Peel Hunt and Numis Securities.
The total number of Ordinary Shares in which Mr Lawson retains an interest is 1,436,744 Ordinary Shares, representing approximately 1.8 per cent. of the total voting rights in the Company.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated
|
||
|
a) |
Name: |
Melvin Lawson
|
|
|
2 |
Reason for the notification
|
||
|
a) |
Position/Status:
|
Non-Executive Director |
|
|
b) |
Initial Notification/Amendment:
|
Initial Notification |
|
|
3 |
Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor
|
||
|
a) |
Name: |
Telecom Plus PLC
|
|
|
b) |
LEI: |
549300QGHDX5UKE58G86
|
|
|
4. |
Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
|
||
|
a) |
Description of the financial instrument:
Identification code: |
Ordinary Shares
ISIN GB0008794710
|
|
|
b) |
Nature of the transaction:
|
Disposal of Ordinary Shares
|
|
|
c) |
Price(s) and volume(s): |
Price(s)
|
Volume(s) |
|
£13.50
|
700,000
|
||
|
d) |
Aggregated price(s) and volume(s): |
Price(s)
|
Volume(s) |
|
N/A
|
N/A
|
||
|
e) |
Date of the Transaction:
|
26 June 2020
|
|
|
f) |
Place of the Transaction: |
London Stock Exchange (XLON)
|
|
|
For further information, please contact: |
|
|
Telecom Plus PLC David Baxter
|
020 8955 5000 |
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
